Puerarin:8-beta-D-Glucopyranosyl-7-hydroxy-3-(4-hydroxyphenyl)-4H-1-.:Introduction and Its Benefit Applications.

Puerarin Safety and Toxicity.

Puerarin CAS 3681-99-0 Anti-Cancer,Antioxidant photo picture image Acute toxicity(LD50):Puerarin.

LD50-Lethal dose,50 percent kill. Intravenous.Rodent-mouse. 738mg/kg.Details of toxic effects not reported other than lethal dose value.Reference:CYLPDN Zhongguo Yaoli Xuebao.Acta Pharmacologica Sinica.Chinese Hournal of Pharmacology.(China International Book Trading Corp.,POB 2820,Beijing,Peop.Rep.China)V.1-1980-Volume(issue)/page/year:6,166,1985)

In order to im- prove the physical and chemical characteristics of puerarin, increase its pharmacological and biologic activities, and decrease its toxicological actions, a number of its derivatives have been synthesized in recent years.

Reference:

1.Puerarin:8-beta-D-Glucopyranosyl-7-hydroxy-3-(4-hydroxyphenyl)-4H-1-.:Introduction and Its Benefit Applications.

last edit date:11th,Mar.2010.

Available Product

Name:Puerarin
Serie No:Pure07.
Specifications:98%99%HPLC.
INCI Name:N/A
EINECS/ELINCS No.:N/A
CAS:3681-99-0
Chem/IUPAC Name:8-beta-D-Glucopyranosyl-7-hydroxy-3-(4-hydroxyphenyl)-4H-1-benzopyran-4-one;

Supplying Conditions